CDKN1B and pituitary tumor: There are currently no cases of pituitary tumors in young individuals with MEN4, suggesting that screening for pituitary tumor development with measurements of prolactin and IGF-1 and MRI may begin in adolescents and not in children as suggested in patients with MEN1 (1).